10-K.Info (Beta Test)
Courtesy of Short Sands, LLC
10-K.Info (Beta Test)
Courtesy of Short Sands, LLC

GILEAD SCIENCES, INC.

Ticker: GILD   Fiscal Year: 2012

Consolidated Statements of Income

Period Ending Dec 31, 2012 10-K (Filed: Feb 27, 2013)

(In Thousands)
 12 Months Ended12 Months Ended12 Months Ended
 Dec 31, 2012Dec 31, 2011Dec 31, 2010
Revenues [Abstract]
Product Sales
$
9,398,371
8,102,3597,389,921
Royalty Revenues290,523268,827545,970
Contract and Other Revenues13,62314,19913,529
Total Revenues9,702,5178,385,3857,949,420
 
Costs and Expenses [Abstract]
Cost of Goods Sold2,471,3632,124,4101,869,876
Research and Development Expenses1,759,9451,229,1511,072,930
Selling, General and Administrative Expenses1,461,0341,241,9831,044,392
Total Costs and Expenses5,692,3424,595,5443,987,198
 
Income from Operations4,010,1753,789,8413,962,222
Interest Expense(360,916)(205,418)(108,961)
Other Income (Expense), net(37,279)66,58160,287
Income Before Provision for Income Taxes3,611,9803,651,0043,913,548
 
Provision for Income Taxes1,038,381861,9451,023,799
Net Income2,573,5992,789,0592,889,749
 
Net Loss Attributable to Noncontrolling Interest17,96714,57811,508
Net Income Attributable to Gilead2,591,5662,803,6372,901,257
 
Net Income Per Share Attributable to Gilead Common Stockholders - Basic (usd per share)1.711.811.69
Shares Used in Per Share Calculation-Basic (shares)1,514,6211,549,8061,712,120
Net Income Per Share Attributable to Gilead Common Stockholders - Diluted (usd per share)1.641.771.66
Shares Used in Per Share Calculation - Diluted (shares)1,582,5491,580,2361,746,792
External Links 
GILEAD SCIENCES, INC. (GILD) Fiscal Year 2012
Statements of 10-K in Excel https://www.sec.gov/.../Financial.xlxs
Complete 10-K in HTML https://www.sec.gov/.../10-K.html
Complete 10-K in XBRL https://www.sec.gov/.../10-K-xbrl.zip